Cited by — Macrophage-mimetic liposomal nanovesicles deliver CXCR2 antagonists to suppress CXCL2-driven breast cancer and atherosclerotic progression | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Macrophage-mimetic liposomal nanovesicles deliver CXCR2 antagonists to suppress CXCL2-driven breast cancer and atherosclerotic progression.
No admitted local citation edges point to this work yet.